Please use this identifier to cite or link to this item:
http://hdl.handle.net/10553/134811
| Title: | Intracochlear Administration of DBOTO Gene Therapy in Pediatric Patients with Profound Hearing Loss Due to Otoferlin Mutations: The CHORD Phase 1/2 Open-Label Trial | Authors: | Lustig, Lawrence Bance, Manohar Ishiyama, Akira Nash, Robert Polo, Ruben Ramos De Miguel, Ángel Manrique Rodriguez, Manuel Jesus Rubinstein, Jay T. Quigley, Tera Riggs, Jason Corrales, Eduardo Anderson, Jeffery Valayannopoulos, Vassili |
UNESCO Clasification: | 32 Ciencias médicas 3201 Ciencias clínicas 320102 Genética clínica |
Issue Date: | 2024 | Journal: | Molecular Therapy | Conference: | ASGCT 27th Annual Meeting Abstracts | URI: | http://hdl.handle.net/10553/134811 | ISSN: | 1525-0016 | Source: | Molecular Therapy[ISSN 1525-0016],v. 32 (4) sup. 1, p. 6, Abstract 10, (Abril 2024) |
| Appears in Collections: | Actas de congresos |
Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.